| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-13 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-12 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-11 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-10 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-09 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-09 |